A detailed history of First Manhattan CO transactions in Astrazeneca PLC stock. As of the latest transaction made, First Manhattan CO holds 6,425 shares of AZN stock, worth $438,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,425
Previous 6,425 -0.0%
Holding current value
$438,185
Previous $501,000 0.2%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $66 - $80
1 Added 0.02%
6,425 $501,000
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $549 - $626
-9 Reduced 0.14%
6,424 $435,000
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $7,241 - $8,105
-117 Reduced 1.79%
6,433 $433,000
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $215,392 - $233,570
3,081 Added 88.82%
6,550 $468,000
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $120,300 - $136,398
-1,905 Reduced 35.45%
3,469 $240,000
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $28,406 - $36,910
524 Added 10.8%
5,374 $364,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $50,369 - $128,962
950 Added 24.36%
4,850 $265,000
Q3 2021

Nov 15, 2021

SELL
$55.56 - $60.79 $66,672 - $72,948
-1,200 Reduced 23.53%
3,900 $234,000
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $183,996 - $228,684
-3,800 Reduced 42.7%
5,100 $305,000
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $36,549 - $42,191
775 Added 9.54%
8,900 $442,000
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $29,092 - $37,334
-675 Reduced 7.67%
8,125 $429,000
Q2 2018

Aug 01, 2018

BUY
$34.55 - $37.05 $138,200 - $148,200
4,000 Added 83.33%
8,800 $308,000
Q1 2018

Apr 20, 2018

SELL
$32.97 - $36.63 $118,692 - $131,868
-3,600 Reduced 42.86%
4,800 $167,000
Q4 2017

Jan 22, 2018

SELL
$32.09 - $34.78 $38,508 - $41,736
-1,200 Reduced 12.5%
8,400 $291,000
Q3 2017

Oct 25, 2017

BUY
$28.96 - $34.0 $278,016 - $326,400
9,600
9,600 $325,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.